(Q44378597)

2 December 2017

title

Gemcitabine and carboplatin in patients with locally advanced or metastatic non-small cell lung cancer: a prospective phase II study (English)

1 reference

2 December 2017

1 reference

C Kortsik

1 reference

2 December 2017

P Albrecht

series ordinal

1 reference

2 December 2017

A Elmer

series ordinal

1 reference

2 December 2017

publication date

1 April 2003

1 reference

2 December 2017

1 reference

2 December 2017

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

85-90

1 reference

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900526-3

7 January 2021

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900526-3

7 January 2021

Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900526-3

7 January 2021

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900526-3

7 January 2021

Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900526-3

7 January 2021

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900526-3

7 January 2021

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900526-3

7 January 2021

Gemcitabine versus gemcitabine/carboplatin in advanced non-small cell lung cancer: preliminary findings in a phase III trial of the Swedish Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900526-3

7 January 2021

10.1016/S0169-5002(02)00526-3

Identifiers

DOI

1 reference

2 December 2017

1 reference